As geopolitical risks in the Middle East have increased market volatility, sector trends are diverging, and in the KOSDAQ market, pharmaceuticals and biotechnology are emerging as new leading sectors. While previously dominant sectors such as semiconductors and secondary batteries have slowed down, indices related to pharmaceuticals and biotech are on an upward trend, with the proportion of biotech companies among the top market-cap stocks expanding significantly.


The market is focusing on the potential for mid- to long-term capital inflows into the pharmaceutical and biotech sectors, especially in connection with KOSDAQ restructuring policies. However, given the sector’s characteristics—where stock price volatility can be high depending on individual events such as clinical trial results or technology transfers—analysts suggest that investors should also examine companies’ growth potential and fundamentals as part of their strategy.

Shift in KOSDAQ Leaders: Pharmaceuticals and Biotech Stand Out Amid Volatile Market View original image

[Industry Leader HisL Stock Loan: https://www.hisl.co.kr?agency=ASIA]


Meanwhile, interest in stock loans continues to increase. Investors keen not to miss out on rare investment opportunities are turning to stock loans, which allow them to leverage more capital for stock purchases.


One of the advantages of stock loans is that even if investors face a forced sale crisis due to a sharp decline in stock prices while using margin or credit, they can easily switch to a stock loan without needing additional collateral or selling their stocks, and then wait for a rebound.


◆ HisL Stock Loan, offering the industry's lowest annual interest rate in the 5% range—not only for additional investment funds, but also for refinancing margin and credit debt!

HisL Stock Loan has launched a securities-linked credit product that any investor can use without burden, offering the lowest annual interest rate in the industry, in the 5% range. It can be used for both stock purchases and refinancing margin or credit debt with securities firms, and allows up to four times leverage, including the investor’s own capital, regardless of credit rating.


In addition, products are available that are not subject to DSR (Debt Service Ratio) for investors who previously found it difficult to use stock loans due to DSR limits. Investors using the Alternative Trading System (NXT) can also take advantage of these services.


Investors who want to learn more about the diverse customized products offered by HisL Stock Loan can contact the customer service center (☎1566-5113) to conveniently consult with a specialist 24 hours a day, regardless of loan approval.


○ Launch of industry’s lowest annual interest rate products in the 5% range

○ DSR-free products available

○ ETF trading possible

○ No.1 market share for 22 consecutive years, Winner of Korea First Brand Awards for 17 consecutive years

○ Real-time repayment of securities firm margin/credit

○ Trading possible on Alternative Trading System (NXT)

○ Reliable consultation quality guarantee system

* HisL Stock Loan Customer Center: 1566-5113

Go to: https://www.hisl.co.kr?agency=ASIA


Samsung Electronics, SK Hynix, Pearl Abyss, Hyundai Motor, Doosan Enerbility



※ The content above does not reflect the editorial direction of The Asia Business Daily, and all responsibility lies with the information provider.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing